$VRDN

$23.34 +$0.97 (4.34%) Close

$VRDN Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Company Executives

$VRDN Management Team

Dr. Radhika Tripuraneni

Chief Medical Officer

Age 45

Compensation -

Sex Female

Mr. Tomas Kiselak

Independent Chairman of the Board

Age 38

Compensation $282.4K USD

Sex Male

Mr. Stephen Mahoney

President

Chief Executive Officer

Director (Principal Executive Officer)

Age 54

Compensation $1.117M USD

Sex Male

Mr. Seth Harmon

Chief Financial Officer

Age 45

Compensation $770.7K USD

Sex Male

Mr. Thomas Beetham

Chief Operating Officer

Age 55

Compensation $809.5K USD

Sex Male

Ms. Jennifer Tousignant

Chief Legal Officer

Age 53

Compensation $4.911M USD

Sex Female

Name / Title	Age	Compensation	Sex
Dr. Radhika Tripuraneni Chief Medical Officer	45	-	Female
Mr. Tomas Kiselak Independent Chairman of the Board	38	$282.4K USD	Male
Mr. Stephen Mahoney President Chief Executive Officer Director (Principal Executive Officer)	54	$1.117M USD	Male
Mr. Seth Harmon Chief Financial Officer	45	$770.7K USD	Male
Mr. Thomas Beetham Chief Operating Officer	55	$809.5K USD	Male
Ms. Jennifer Tousignant Chief Legal Officer	53	$4.911M USD	Female

Board of Directors

From the proxy statement filed Apr 17, 2026

Directors

serving now

Independent

6 of 7

stated in the proxy

Average tenure

3.9 years

from year joined

CEO also chairs the board

Tomas Kiselak

Director	Age	On board	Independent	Committees	Other public boards	2025 pay
Stephen Mahoney CEO	55	2023 3 years	Not independent	None stated	None stated	Paid as CEO
Jeff Ajer	63	2025 1 year	Independent	None stated	Nektar Therapeutics	$598,246
Chris Cain, Ph.D.	42	2025 1 year	Independent	None stated	Cogent Biosciences, Inc., Jade Biosciences, Inc., Damora Therapeutics, Inc.	Not stated
Sarah Gheuens, M.D., Ph.D.	47	2023 3 years	Independent	None stated	None stated	Not stated
Tomas Kiselak Board chair	39	2020 6 years	Independent	None stated	Apogee Therapeutics, Inc.	$293,902
Jennifer K. Moses	51	2021 5 years	Independent	None stated	None stated	$268,902
Arlene M. Morris	74	2018 8 years	Independent	None stated	Palatin Technologies, Inc., Edgewise Therapeutics, Inc., Cogent Biosciences, Inc.	$271,402

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

We could not read related-party transactions reliably

Rather than show a list that might be incomplete, we show nothing. They are in the proxy filed Apr 17, 2026, in its related person transactions section.

Read them in the proxy

Comments

Company Executives

$VRDN Management Team

Dr. Radhika Tripuraneni

Mr. Tomas Kiselak

Mr. Stephen Mahoney

Mr. Seth Harmon

Mr. Thomas Beetham

Ms. Jennifer Tousignant

Board of Directors

Related-party transactions

We could not read related-party transactions reliably